Model Medicines to Keynote CPHI Middle East

Model Medicines is proud to participate in CPHI Middle East 2024, the region's premier pharmaceutical conference proudly supported by the Saudi Arabia Ministry of Health. As Saudi Arabia emerges as a global biotechnology leader with a pharmaceutical market valued at $12.1 billion USD, this prestigious event brings together industry pioneers to discuss innovation, digital transformation, and the future of drug discovery.Featured Speaking Engagements

Keynote Presentation

When Digitalisation Fails: Facing Digital Shortcomings

December 12th, 14:45-15:15 | Future Stage

Join Daniel Haders, CEO of Model Medicines, as he delivers a compelling keynote addressing the critical challenges and opportunities in pharmaceutical digitalization. Drawing from extensive industry experience, Haders will explore:Common pitfalls in digital transformation initiativesStrategic approaches to overcome implementation challengesReal-world case studies and practical solutionsFuture outlook for digital innovation in pharma

Expert Panel Discussion

Exploring AI Potential in Pharma for Drug Discovery and Development

December 12th, 11:15-12:00 | Future Stage

Daniel Haders joins industry leaders in a dynamic panel discussion moderated by Dean Calhoun, President/CEO of Affygility Solutions. Alongside Thrasyvoulos (Thras) Karydis, Co-Founder and CTO of DeepCure, the panel will delve into:Latest developments in AI-driven drug discoveryImpact of artificial intelligence on development timelinesFuture possibilities for AI in pharmaceutical innovationCollaborative opportunities in the Middle East's growing biotech sector

About CPHI Middle East 2024

As Saudi Arabia positions itself for biotech leadership with ambitious plans for:Self-sufficiency in vaccine productionAdvanced biomanufacturing capabilitiesCutting-edge genomics researchCPHI Middle East serves as the perfect platform for industry leaders to connect, innovate, and shape the future of pharmaceuticals in the region. The event showcases data-driven solutions, breakthrough research, and innovative formulation strategies, supported by the Saudi Arabia Ministry of Health's commitment to advancing healthcare and pharmaceutical excellence.